TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
L’Oréal North Asia Chief Financial Officer Pietro Andrea Brambilla has joined the boards of Yichang Tianmei International Cosmetics and Suzhou Beautycos International, replacing Guillaume Dauchy. L’Oréal North Asia President and China CEO Vincent Boinay remains chairman of both companies. The company’s announcement does not specify the effective date or describe changes to the subsidiaries’ operations.
L’Oréal North Asia Chief Financial Officer Pietro Andrea Brambilla has joined the boards of two of the group’s major Chinese manufacturing subsidiaries, replacing Guillaume Dauchy. The appointments put a senior regional finance executive on the boards of Yichang Tianmei International Cosmetics and Suzhou Beautycos International, while L’Oréal North Asia President and China CEO Vincent Boinay remains chairman of both companies.
Brambilla’s appointments cover two production businesses with different roles in L’Oréal’s regional manufacturing network. Yichang Tianmei International Cosmetics operates what the report describes as L’Oréal’s largest makeup manufacturing facility in Asia-Pacific. Suzhou Beautycos International is described as one of the group’s largest skincare production sites globally. The reported board changes do not indicate that either facility’s production or day-to-day management is changing.
Brambilla joined L’Oréal in 2004 and has held senior financial positions in China since 2017, according to the report. He currently serves as the group’s North Asia CFO. The source says he replaces Dauchy on both subsidiary boards, but does not provide Dauchy’s former title or explain whether he will take on another role within L’Oréal.
The report presents the appointments as a governance change intended to bring oversight of the manufacturing subsidiaries into closer alignment with L’Oréal’s North Asia leadership. It identifies Boinay as chairman of both boards after the appointments. No further changes to board membership, corporate leadership or the facilities’ operating arrangements were reported.
Finance Leadership Joins Factory Boards
Adding the regional CFO to the boards gives L’Oréal’s senior North Asia finance leadership a formal role in governance at two major production subsidiaries. That may support closer coordination between regional management and the businesses responsible for manufacturing makeup and skincare products. The source describes this as a strengthening of governance and financial oversight; it does not provide evidence of a particular financial change, new investment or operational decision resulting from the appointments.
The locations named in the report matter because the subsidiaries are characterized as significant production sites in L’Oréal’s network. Board appointments can affect how senior executives oversee corporate entities, but the announcement as reported does not disclose any new policies, targets or changes to production. For readers tracking the company’s China operations, the confirmed development is a change in board representation, rather than a reported shift in manufacturing strategy.
L’Oréal skincare manufacturing equipment
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Brambilla’s China Finance Experience
Brambilla joined L’Oréal in 2004 and has worked in senior finance positions in China since 2017, according to the source report. His appointment places an executive with several years of China-based financial experience on the boards of two local manufacturing subsidiaries. The supplied material does not list his earlier positions or set out the responsibilities attached to his new board roles.
The two subsidiaries are presented as important to L’Oréal’s cosmetics production: Yichang Tianmei for makeup manufacturing in Asia-Pacific and Suzhou Beautycos for skincare production globally. Those descriptions provide the operational context for the board changes, but the source does not give facility output, workforce figures, investment amounts or a comparison with other sites. The reported governance update therefore establishes who is joining the boards and which companies are involved, without quantifying the facilities’ production contribution.
“The appointments bring governance of L’Oréal’s major Chinese manufacturing operations into closer alignment with its North Asia leadership structure.”
— Global Cosmetics News, citing Jing Daily
As an affiliate, we earn on qualifying purchases.
Effective Date and Role Details
The supplied report does not state when the appointments take effect, whether the relevant corporate filings have been completed, or whether the changes have already been formalized. It also does not explain Dauchy’s next position, give details of the boards’ full membership, or specify what additional duties Brambilla will have as a director.
There is no reported change to production, investment, staffing or facility leadership associated with the appointments. The source characterizes the change as an alignment of governance and financial oversight, but provides no further detail on how the boards’ work will change or what measures will be used to evaluate its effect.
As an affiliate, we earn on qualifying purchases.
Watch for Filing and Operating Updates
The next confirmable milestones would be any company or registry disclosures specifying the effective date and formal board composition, along with any further information from L’Oréal about Brambilla’s responsibilities. The supplied report does not give a timetable for those details or identify a scheduled announcement.
Until additional information is published, the confirmed development is limited to Brambilla replacing Dauchy on the two subsidiary boards, with Boinay continuing as chairman. Any claim that the appointments will alter production or investment at Yichang or Suzhou would go beyond what the report establishes.
As an affiliate, we earn on qualifying purchases.
Key Questions
Which L’Oréal subsidiaries are affected?
The appointments concern Yichang Tianmei International Cosmetics and Suzhou Beautycos International, both Chinese cosmetics manufacturing subsidiaries.
Who is joining the boards?
Pietro Andrea Brambilla, L’Oréal’s North Asia CFO, is joining both boards. The report says he replaces Guillaume Dauchy.
Who will chair the subsidiaries?
Vincent Boinay, L’Oréal North Asia President and China CEO, remains chairman of both companies, according to the report.
Will the appointments change manufacturing operations?
No operational change was reported. The source describes the appointments as a governance and oversight change, and does not say that production, staffing or investment plans will change.
When do the board appointments take effect?
The supplied report does not give an effective date or explain whether the appointments have been recorded in corporate filings.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
